MBL2 gene variation affecting serum MBL is associated with prosthetic joint infection in Czech patients after total joint arthroplasty

Tissue Antigens

Volumn 80, Issue 5, 2012, Pages 444-451

  Navratilova, Z ^a   Gallo, J ^b   Mrazek, F ^a   Lostak, J ^b   Petrek, M ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

Author keywords

Gene variants; Hip; Knee; Mannose binding lectin; Polymorphisms; Prosthetic joint infection; Total joint arthroplasty

Indexed keywords

GENOMIC DNA; MANNOSE BINDING LECTIN 2;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CZECH REPUBLIC; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE FREQUENCY; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; HUMAN CELL; INFECTION RISK; JOINT PROSTHESIS; MAJOR CLINICAL STUDY; MALE; MBL2 GENE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTHESIS INFECTION; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

ADULT; AGED; ALLELES; ARTHROPLASTY; CASE-CONTROL STUDIES; CZECH REPUBLIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INFLAMMATION; JOINTS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; OSTEOARTHRITIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84866925425     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12001     Document Type: Article

References (42)

1. Katz JN. Total joint replacement in osteoarthritis. Best Pract Res Clin Rheumatol 2006: 20: 145-53.
2. Gallo J, Kolár M, Novotný R, Riháková P, Tichá V. Pathogenesis of prosthesis-related infection. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003: 147: 27-35.
3. Ong KL, Kurtz SM, Lau E, Bozic KJ, Berry DJ, Parvizi J. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty 2009: 24: 105-9.
4. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007: 89: 780-5.
5. Jämsen E, Furnes O, Engesaeter LB et al. Prevention of deep infection in joint replacement surgery. Acta Orthop 2010: 81: 660-6.
6. van de Vosse E, van Dissel JT, Ottenhoff TH. Genetic deficiencies of innate immune signalling in human infectious disease. Lancet Infect Dis 2009: 9: 688-98.
7. Garred P. Mannose-binding lectin genetics: from A to Z. Biochem Soc Trans 2008: 36: 1461-6.
8. Kakkanaiah VN, Shen GQ, Ojo-Amaize EA, Peter JB. Association of low concentrations of serum mannose-binding protein with recurrent infections in adults. Clin Diagn Lab Immunol 1998: 5: 319-21.
9. Rantala A, Lajunen T, Juvonen R et al. Mannose-binding lectin concentrations, MBL2 polymorphisms, and susceptibility to respiratory tract infections in young men. J Infect Dis 2008: 198: 1247-53.
10. De Benedetti F, Auriti C, D'Urbano LE et al. Low serum levels of mannose binding lectin are a risk factor for neonatal sepsis. Pediatr Res 2007: 61: 325-8.
11. Summerfield JA, Sumiya M, Levin M, Turner MW. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ 1997: 314: 1229-32.
12. Summerfield JA, Ryder S, Sumiya M et al. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet 1995: 345: 886-9.
13. Siassi M, Hohenberger W, Riese J. Mannan-binding lectin (MBL) serum levels and post-operative infections. Biochem Soc Trans 2003: 31: 774-5.
14. Gallo J, Kolar M, Dendis M et al. Culture and PCR analysis of joint fluid in the diagnosis of prosthetic joint infection. New Microbiol 2008: 31: 97-104.
15. Schmalzried TP, Amstutz HC, Au MK, Dorey FJ. Etiology of deep sepsis in total hip arthroplasty. The significance of hematogenous and recurrent infections. Clin Orthop Relat Res 1992: 280: 200-7.
16. Trampuz A, Zimmerli W. Prosthetic joint infections: update in diagnosis and treatment. Swiss Med Wkly 2005: 135: 243-51.
17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
18. Bunce M, O'Neill CM, Barnardo MC et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilising sequence-specific primers (PCR-SSP). Tissue Antigens 1995: 46: 355-67.
19. Cermakova Z, Petrkova J, Arakelyan A et al. MCP-1 -2518 (A to G) single nucleotide polymorphism is not associated with myocardial infarction in the Czech population. Int J Immunogenet 2005: 32: 315-8.
20. Phillips JE, Crane TP, Noy M, Elliott TS, Grimer RJ. The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br 2006: 88: 943-8.
21. Rice TK, Schork NJ, Rao DC. Methods for handling multiple testing. Adv Genet 2008: 60: 293-308.
22. Lalouel JM, Rohrwasser A. Power and replication in case-control studies. Am J Hypertens 2002: 15: 201-5.
23. Schneider S, Roessli D, Excoffier L. Arlequin ver. 2.000: A software for population genetics data analysis. Switzerland: Genetics and Biometry Laboratory, University of Geneva, 2000.
24. Malik MH, Bayat A, Jury F, Kay PR, Ollier WE. Genetic susceptibility to total hip arthroplasty failure-positive association with mannose-binding lectin. J Arthroplasty 2007: 22: 265-70.
25. Skalnikova H, Freiberger T, Chumchalova J, Grombirikova H, Sediva A. Cost-effective genotyping of human MBL2 gene mutations using multiplex PCR. J Immunol Methods 2004: 295: 139-47.
26. Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lecitin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods 2000: 241: 33-42.
27. Boldt AB, Messias-Reason IJ, Meyer D et al. Phylogenetic nomenclature and evolution of mannose-binding lectin (MBL2) haplotypes. BMC Genet 2010: 11: 38.
28. Ip WK, Takahashi K, Moore KJ, Stuart LM, Ezekowitz RA. Mannose-binding lectin enhances Toll-like receptors 2 and 6 signaling from the phagosome. J Exp Med 2008: 205: 169-81.
29. Fournier B, Philpott DJ. Recognition of Staphylococcus aureus by the Innate Immune System. Clin Microbiol Rev 2005: 18: 521-40.
30. Hruz P, Zinkernagel AS, Jenikova G et al. NOD2 contributes to cutaneous defense against Staphylococcus aureus through α-toxin-dependent innate immune activation. Proc Natl Acad Sci USA 2009: 106: 12873-8.
31. Ishii M, Ohsawa I, Inoshita H et al. Serum concentration of complement components of the lectin pathway in maintenance hemodialysis patients, and relatively higher levels of L-Ficolin and MASP-2 in Mannose-binding lectin deficiency. Ther Apher Dial 2011: 5: 441-7.
32. Dean MM, Flower RL, Eisen DP, Minchinton RM, Hart DN, Vuckovic S. Mannose-binding lectin deficiency influences innate and antigen-presenting functions of blood myeloid dendritic cells. Immunology 2011: 132: 296-305.
33. Malik MH, Bayat A, Jury F, Ollier WE, Kay PR. Genetic susceptibility to hip arthroplasty failure-association with the RANK/OPG pathway. Int Orthop 2006: 30: 177-81.
34. Malik MH, Jury F, Bayat A, Ollier WE, Kay PR. Genetic susceptibility to total hip arthroplasty failure: a preliminary study on the influence of matrix metalloproteinase 1, interleukin 6 polymorphisms and vitamin D receptor. Ann Rheum Dis 2007: 66: 1116-20.
35. Fraser DA, Bohlson SS, Jasinskiene N et al. C1q and MBL, components of the innate immune system, influence monocyte cytokine expression. J Leukoc Biol 2006: 80: 107-16.
36. Shi L, Takahashi K, Dundee J et al. Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med 2004: 199: 1379-90.
37. Chalmers JD, Fleming GB, Hill AT, Kilpatrick DC. Impact of mannose-binding lectin insufficiency on the course of cystic fibrosis: a review and meta-analysis. Glycobiology 2011: 21: 271-82.
38. Gallo J, Mrazek F, Petrek M. Variation in cytokine genes can contribute to severity of acetabular osteolysis and risk for revision in patients with ABG 1 total hip arthroplasty: a genetic association study. BMC Med Genet 2009: 10: 109.
39. Pedersen AB, Svendsson JE, Johnsen SP, Riis A, Overgaard S. Risk factors for revision due to infection after primary total hip arthroplasty. A population-based study of 80, 756 primary procedures in the Danish Hip Arthroplasty Registry. Acta Orthop 2010: 81: 542-7.
40. Berbari EF, Hanssen AD, Duffy MC et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 1998: 27: 1247-54.
41. von Elm E, Moher D, Little J, STREGA collaboration. Reporting genetic association studies: the STREGA statement. Lancet 2009: 374: 98-100.
42. Del Buono A, Denaro V, Maffulli N. Genetic susceptibility to aseptic loosening following total hip arthroplasty: a systematic review. Br Med Bull 2012: 101: 39-55.